Measuring Single Neuron Activity in the Brain

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity College, London

About this trial

The SUNAN (Single Unit Neurophysiological Architecture of the Neocortex) study aims to understand how individual brain cells called neurons interact and communicate, and how the neurons can be affected in neurological disease. Using an advanced digital probe called the "Neuropixels probe," which is as thin as a human hair, the investigators can record electrical activity from individual neurons on the outmost layer of the brain (cerebral cortex). This electrical (neurophysiological) activity recording technique allows the investigators to isolate and monitor single-neuron activity from the human brain during planned neurosurgical operations in real time.

Eligibility criteria

Qualifiers

Aged 18 years and over.

Documented informed consent to participate.

Resected e.g., as removal of part of a tumour or epilepsy focused. Or

Transgressed as part of the surgical approach to reach a deeper target e.g., resection of a deep tumour or cavernoma.

Disqualifiers

Participants who lack the capacity to give informed consent.

Participants who are pregnant or breast feeding at the time of surgery.

Participants deemed to be unsuitable for recruitment to the study by the responsible Consultant Neurosurgeon. If in the view of the treating consultant involvement in the study would compromise the patient's surgery or present an unacceptable risk to them, they will not be recruited to the study. For example, if the participant does not meet the standard of care preoperative checks.

Concern from the Consultant Neurosurgeon or treating Anaesthetist that there would be an unreasonable burden on the patient to participate in the study. For example, risk due to increased length of anaesthetic time.

Trial design

Treatments tested in this trial

  • Neuropixels recording intraoperatively during planned neurosurgery

Treatment groups

50 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

University College, London

Lead sponsor

Francis Crick Institute

Collaborator